Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Isacson

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Cell Stem Cell|December 3, 2009
Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathwaySangmi Chung, Amanda Leung, Baek-Soo Han, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 4, 2016
hVMAT2: A Target of Individualized Medication for Parkinson's DiseaseNian Xiong, Nuomin Li, Eden Martin, et al.
Neurobiology of Disease|January 7, 2014
Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's diseaseSian E Davies, Penelope J Hallett, Thomas Moens, et al.
Cell|March 10, 2009
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factorsFrank Soldner, Dirk Hockemeyer, Caroline Beard, et al.
Plos One|March 28, 2015
A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C)Gaynor A Smith, Emily M Rocha, Thomas Rooney, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2010
Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian ratsGunnar Hargus, Oliver Cooper, Michela Deleidi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease modelsHaruhisa Inoue, Ling Lin, Xinhua Lee, et al.
Stem Cells (Dayton, Ohio)|August 27, 2005
Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cellsDong-Wook Kim, Sangmi Chung, Mikyeong Hwang, et al.
Neurobiology of Disease|September 23, 2015
Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neuronsEmily M Rocha, Gaynor A Smith, Eric Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat modelLars M Bjorklund, Rosario Sánchez-Pernaute, Sangmi Chung, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Cell Stem Cell|December 3, 2009
Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathwaySangmi Chung, Amanda Leung, Baek-Soo Han, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 4, 2016
hVMAT2: A Target of Individualized Medication for Parkinson's DiseaseNian Xiong, Nuomin Li, Eden Martin, et al.
Neurobiology of Disease|January 7, 2014
Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's diseaseSian E Davies, Penelope J Hallett, Thomas Moens, et al.
Cell|March 10, 2009
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factorsFrank Soldner, Dirk Hockemeyer, Caroline Beard, et al.
Plos One|March 28, 2015
A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C)Gaynor A Smith, Emily M Rocha, Thomas Rooney, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2010
Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian ratsGunnar Hargus, Oliver Cooper, Michela Deleidi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease modelsHaruhisa Inoue, Ling Lin, Xinhua Lee, et al.
Stem Cells (Dayton, Ohio)|August 27, 2005
Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cellsDong-Wook Kim, Sangmi Chung, Mikyeong Hwang, et al.
Neurobiology of Disease|September 23, 2015
Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neuronsEmily M Rocha, Gaynor A Smith, Eric Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat modelLars M Bjorklund, Rosario Sánchez-Pernaute, Sangmi Chung, et al.
Pageof 14